Drug Profile
Testosterone oral - ZyVersa Therapeutics
Alternative Names: VAR 100Latest Information Update: 25 Aug 2023
Price :
$50
*
At a glance
- Originator Variant pharmaceuticals
- Developer ZyVersa Therapeutics
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypogonadism
Most Recent Events
- 25 Aug 2023 Discontinued - Preclinical for Hypogonadism in USA (PO) (ZyVersa Therapeutics pipeline, August 2023)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Hypogonadism in USA (PO)
- 01 May 2019 Variant Pharmaceuticals is now called ZyVersa Therapeutics